Aquestive Therapeutics, Inc.: accounts_payable
| Value | {"amount": 11889000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2026-03-31) |
| Status | current |
| Entity | Aquestive Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:35:24.527382+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b7bedd99-b121-4ee9-92a6-8e99b44cb550
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001398733-26-000030Retrieved: 2026-08-19T13:35:24.527382+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001398733/accounts-payable/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b7bedd99-b121-4ee9-92a6-8e99b44cb550
History
- no predecessors — first report